Does rosmarinic acid underestimate as an experimental cardiovascular drug?;Seria o ácido rosmarínico subestimado como droga cardiovascular experimental?

Acta Cirurgica Brasileira

Volumn 28, Issue SUPPL.1, 2013, Pages 83-87

  Ferreira, Luciana Garros ^a   Celotto, Andrea Carla ^a   Capellini, Verena Kise ^a   Albuquerque, Agnes Afrodite Sumarelli ^a   de Nadai, Talesrubens ^a   de Carvalho, Marco Tulio Menezes ^a   Evora, Paulo Roberto Barbosa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiovascular diseases; Polyphenols; Rosmarinus officinalis

Indexed keywords

ROSMARINIC ACID; CARDIOVASCULAR AGENT; CINNAMIC ACID DERIVATIVE; DEPSIDE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; HUMAN; HYPERTENSION; INFLAMMATION; MEMORY DISORDER; NEOPLASM; PARKINSON DISEASE; PREVALENCE; ROSEMARY; SEPSIS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR DISEASE; REVIEW;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CINNAMATES; DEPSIDES; HUMANS;

EID: 84873695556     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502013001300016     Document Type: Article

References (23)

1. Scarpati ML, Oriente G. Isolamento e costituzione dell'acido rosmarinico (dal rosmarinus off.). Ricerca Sci. 1958;28:2329-2333.
2. Parnham MJ, Kesselring K. Rosmarinic acid. Drugs Future. 1985;10:756-757.
3. Fuhrman B, Volkova N, Rosenblat M, Aviram M. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid Redox Signal. 2000;2:491-506.
4. Takeda H, Tsuji M. Inazu M, Egashira T, Matsumiya T. Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice. Eur J Pharmacol. 2002;449:261-267.
5. Petersen M, Simmonds MS. Rosmarinic acid. Phytochemistry. 2003;62:121-125.
6. Osakabe N, Yasuda A, Natsume M, Yoshikawa T. Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis. 2004;25:549-557.
7. Takano H, Osakabe N, Sanbongi C, Yanagisawa R, Inoue K, Yasuda A, Natsume M, Baba S, Ichiishi E, Yoshikawa T. Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, inhibits seasonal allergic rhinoconjunctivitis in humans. Exp Biol Med (Maywood). 2004;229:247-254.
8. Huang SS, Zheng RL. Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett. 2006;239:271-280.
9. Koukoulitsa C, Zika C, Geromichalos GD, Demopoulos VJ, Skaltsa H. Evaluation of aldose reductase inhibition and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. hirtum. Bioorg Med Chem. 2006;14:1653-659.
10. Dubois M, Bailly F Mbemba G, Mouscadet JF, Debyser Z, Witvrouw M, Cotelle P. Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents. J Med Chem. 2008;51:2575-2579.
11. Furtado MA, De Almeida LC, Furtado RA, Cunha WR, Tavares DC. Antimutagenicity of rosmarinic acid in Swiss mice evaluated by the micronucleus assay. Mutat Res. 2008;657:150-154.
12. Sa CM, Ramos AA, Azevedo MF, Lima CF, Fernandes-Ferreira M, Pereira-Wilson C. Sage tea drinking improves lipid profile and antioxidant defences in humans. Int J Mol Sci. 2009;10:3937-3950.
13. Fadel O, El Kirat K, Morandat S. The natural antioxidant rosmarinic acid spontaneously penetrates membranes to inhibit lipid peroxidation in situ. Biochim Biophys Acta. 2011;1808:2973-2980.
14. Ellis BE, Towers GH. Biogenesis of rosmarinic acid in Mentha. Biochem J. 1970;118:291-297.
15. al-Sereiti MR, Abu-Amer KM, Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol. 1999;37:124-130.
16. Tsibul'skǐ AV, Popov AM, Artiukov AA, Kostetskǐ ÉIa, Krivoshapko ON, Mazeǐka AN, Kozlovskaia ÉP. The comparative study of the medical action of lyuteolin, rosmarinic acid and echinochrom A at experimental stress-induced cardiopathology. Biomed Khim. 2011;57:314-325.
17. Kim DS, Kim HR, Woo ER, Hong ST, Chae HJ, Chae SW. Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signalregulated kinase. Biochem Pharmacol. 2005;70:1066-1078
18. Psotová J, Chlopcíková S, Miketová P, Simánek V. Cytoprotectivity of Prunella vulgaris on doxorubicin-treated rat cardiomyocytes. Fitoterapia. 2005;76:556-561.
19. Chlopcíková S, Psotová J, Miketová P, Sousek J, Lichnovský V, Simánek V. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part II. caffeic, chlorogenic and rosmarinic acids. Phytother Res. 2004;18:408-413.
20. Karthik D, Viswanathan P, Anuradha CV. Administration of rosmarinic acid reduces cardiopathology and blood pressure through inhibition of p22phox NADPH oxidase in fructose-fed hypertensive rats. J Cardiovasc Pharmacol. 2011;58:514-521.
21. Li QL, Li BG, Zhang Y, Gao XP, Li CQ, Zhang GL. Three angiotensin-converting enzyme inhibitors from Rabdosia coetsa. Phytomedicine. 2008;15:386-388.
22. Ersoy S, Orhan I, Turan NN, Sahan G, Ark M, Tosun F. Endotheliumdependent induction of vasorelaxation by Melissa officinalis L. ssp. officinalis in rat isolated thoracic aorta. Phytomedicine. 2008;15:1087-1092.
23. Fernandes L, Fortes ZB, Casarini DE, Nigro D, Tostes RC, Santos RA, de Carvalho MH. Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR. Regul Pept. 2005;127:183-189.